Literature DB >> 3981294

Cell culture of rabbit meniscal fibrochondrocytes: proliferative and synthetic response to growth factors and ascorbate.

R J Webber, M G Harris, A J Hough.   

Abstract

This study was undertaken to determine whether the cells of the fibrocartilaginous meniscal substance are capable of proliferation and matrix synthesis. Cells were isolated from the fibrocartilaginous menisci of young New Zealand white rabbits, and grown in two alternative culture regimens differing only in the basal nutrient medium used to initiate primary monolayer growth. Under each culture regimen, the cells attached and proliferated both initially and after passage into secondary (2 degrees) culture. Differences were noted in cell morphology and time to reach confluence in primary (1 degrees) culture. Upon passage into 2 degrees culture, the fibrochondrocytes assumed two distinct morphologies depending upon the type of medium used for 1 degree culture. These morphological changes were accompanied by differences in the population doubling time and incorporation of 35SO4 into sulfated proteoglycans. The proliferation of both fibrochondrocyte subtypes was stimulated by the addition of either pituitary fibroblast growth factor (FGF) or human platelet lysate in a dose-dependent manner. Both FGF (10 ng/ml) and ascorbate (40 micrograms/ml) decreased 35-sulfate incorporation, whereas only ascorbate was found to alter the amount of sulfated glycosaminoglycan in the pericellular coat. We conclude that the fibrochondrocytes of the meniscal substance are capable of replication and synthesis of matrix macromolecules if given the proper stimuli. Additionally, there may be two subpopulations of fibrochondrocytes that can be distinguished by their in vitro behavior.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3981294     DOI: 10.1002/jor.1100030104

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  24 in total

Review 1.  The menisci: basic science and advances in treatment.

Authors:  E Rath; J C Richmond
Journal:  Br J Sports Med       Date:  2000-08       Impact factor: 13.800

Review 2.  Fibrocartilage.

Authors:  M Benjamin; E J Evans
Journal:  J Anat       Date:  1990-08       Impact factor: 2.610

3.  Meniscus Repair and Regeneration: A Systematic Review from a Basic and Translational Science Perspective.

Authors:  John Twomey-Kozak; Chathuraka T Jayasuriya
Journal:  Clin Sports Med       Date:  2020-01       Impact factor: 2.182

4.  The meniscal healing process.

Authors:  Pilar Martínez de Albornoz; Francisco Forriol
Journal:  Muscles Ligaments Tendons J       Date:  2012-06-17

Review 5.  The menisci of the knee joint. Anatomical and functional characteristics, and a rationale for clinical treatment.

Authors:  K Messner; J Gao
Journal:  J Anat       Date:  1998-08       Impact factor: 2.610

Review 6.  Gene therapy in sports medicine.

Authors:  C Lamsam; F H Fu; P D Robbins; C H Evans
Journal:  Sports Med       Date:  1998-02       Impact factor: 11.136

7.  Augmented meniscal healing with free synovial autografts: an organ culture model.

Authors:  M Ochi; Y Mochizuki; M Deie; Y Ikuta
Journal:  Arch Orthop Trauma Surg       Date:  1996       Impact factor: 3.067

8.  Augmentation techniques for isolated meniscal tears.

Authors:  Samuel A Taylor; Scott A Rodeo
Journal:  Curr Rev Musculoskelet Med       Date:  2013-06

9.  Postnatal deletion of Alk5 gene in meniscal cartilage accelerates age-dependent meniscal degeneration in mice.

Authors:  Quan Wang; Qiaoyan Tan; Wei Xu; Liang Kuang; Bin Zhang; Zuqiang Wang; Zhenhong Ni; Nan Su; Min Jin; Can Li; Wanling Jiang; Junlan Huang; Fangfang Li; Ying Zhu; Hangang Chen; Xiaolan Du; Di Chen; Chuxia Deng; Huabing Qi; Yangli Xie; Lin Chen
Journal:  J Cell Physiol       Date:  2018-08-05       Impact factor: 6.384

10.  Effects of TGF-beta1 and hydrostatic pressure on meniscus cell-seeded scaffolds.

Authors:  Najmuddin J Gunja; Rajesh K Uthamanthil; Kyriacos A Athanasiou
Journal:  Biomaterials       Date:  2008-11-05       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.